About 3DHEALS Company Directory:

3DHEALS updates this collection of public and private companies, government and non-government institutions, and any relevant research organizations in healthcare 3D printing, bioprinting, AR/VR, 3D technologies, on a weekly basis. Access to this directory is free to 3DHEALS Premium and Enterprise members. 

THIS CONTENT IS FOR PREMIUM AND ENTERPRISE MEMBERS ONLY.

Add your company to 3DHEALS Directory:

(Please click the same above buttons for significant updates of your organizational information. Map is updated monthly.)

blank

FEOPS

AI-enabled personalized structural heart disease management

Headquarters Technologiepark-Zwijnaarde 122 Gent 9052 Belgium
  • blank
Categories: Simulation, Software
CEO: Matthieu De Beule Phone: +32 9 292 80 30
Links:

Details

FEops’ cutting-edge technology transforms cardiac images into digital twins, virtual copies of the heart or its substructures. With this technology, FEops aims to improve and expand personalized management for patients with structural heart disease. It’s FEops vision that combining digital twins with AI-enabled anatomical analyses generates data-driven insights aspiring to enhance and improve structural heart disease management, spanning from patient selection, procedure planning, periprocedural guidance to patient follow-up. The CE-marked and FDA-cleared FEops HEARTguide technology enables healthcare professionals to improve both procedure efficiency and clinical outcomes. It also empowers Medtech companies to bring superior products to the market faster than ever before

CBD for pain is gaining traction as a complementary option for everyday discomfort, offering potential anti-inflammatory benefits and calmer sensations without strong sedatives. Results vary, so start with a low dose, choose reputable full- or broad-spectrum products, and monitor changes. Always consult a healthcare professional if you have underlying conditions or take other medications. cbdclub.top